Clever Leaves enters the Australian market with a supply agreement with Cannatrek | Releases | America Edition

Clever Leaves enters the Australian market with a supply contract with Cannatrek

The company will supply semi-finished private label CBD products for purchase and distribution to the market through Australian networks of doctors and pharmacies

BOGOTÁ, August 11, 2020 (GLOBE NEWSWIRE) – Smart sheets (the “Company”), a leading multinational operator (MNO) and licensed producer of pharmaceutical grade medicinal cannabinoids, today announced that it has entered the Australian market with the arrival of its first shipment of the private label semi-finished product to Cannatrek, an Australian producer of medicinal cannabis from seed to the patient. The two-year supply contract includes several concentrations of CBD oral solution for distribution through Australian pharmacies and medical networks. In accordance with all relevant import and export regulations, the initial shipment of the product was successfully received by Cannatrek last week and is available for purchase on the market.

The supply contract offers products that are currently not available in Australia and strongly positions both parties in the growing Australian medical cannabis market. Under the terms of the Australian medical cannabis regulation, all products in the agreement meet the manufacturing and testing requirements of the Australian Therapeutic Products (Standard for Medicinal Cannabis) (TGO 93).

“We are pleased to expand our global presence and distribute Clever Leaves marijuana products through networks of doctors and pharmacies across Australia. We look forward to working closely with Cannatrek to increase patients’ access to medical cannabis solutions by leveraging their network. trusted retail brands and proprietary brands, “said Kyle Detwiler, CEO of Clever Leaves.

Related:   Masks, meetings: facing Covid, Castex announces a new twist

Cannatrek CEO Tommy Huppert commented: “Clever Leaves’ entry into the emerging medical cannabis market in Australia through Cannatrek’s distribution network demonstrates not only its commitment to our market, but also its confidence in Cannatrek. As its partner. Australian distribution industry The global cannabis industry is maturing at a very fast pace, and we look forward to launching quality products through our robust and growing network in Australia. We are very excited to have established this relationship with Clever Leaves. our mission to bring unique and affordable medical cannabis products to Australian patients to meet their health needs. “

“Clever Leaves continues to focus on becoming an internationally recognized and trusted source of pharmaceutical grade cannabis products and we continue to seek partnerships with organizations, such as Cannatrek, with a proven track record in the industry. The deal underscores the demand for products the growth of medical cannabis products in Australia and the ability of Clever Leaves to develop commercial partnerships to reach new markets and expand patient care are fast, “said Andrés Fajardo, President of Clever Leaves.

Domestic demand for cannabis products continues to grow rapidly in Australia. According to New Frontier Data, in December 2020, the market will support a projection of 25,000 to 30,000 active patients and, based on the current growth rate, Australian health regulators expect the number of cannabis prescriptions to reach at least 70,000.

Clever Leaves continues to partner with companies worldwide to offer European Union GMP certified products through its vertically integrated business platform and experience in supply chain processes. For all business inquiries, visit the Clever Leaves direct sales platform,, to arrange a meeting with a Clever Leaves business consultant.

Related:   Facebook eliminated twice as much hate content in full advertising boycott | Society | America Edition

About Clever Leaves International Inc.
Clever Leaves is a multinational cannabis company with a mission to operate in compliance with federal and state laws and with an emphasis on large-scale cultivation and processing of ecologically sustainable and pharmaceutical quality medical cannabis, as the focal points of its industry. global cannabis business. With operations and investments in Canada, Colombia, Germany, Portugal and the United States, Clever Leaves has built an efficient distribution network and global presence, based on rapid growth and capital efficiency. Clever Leaves aspires to be the leading global cannabis company in the industry, recognized for its principles, its people and its membership, while promoting a healthier global community.

On July 27, 2020, Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves” or “Company”) jointly announced that they have entered into a definitive agreement (the “Business Combination Agreement”), pursuant to which a newly formed holding company, Clever Leaves Holdings Inc., (“Holdco”) will acquire SAMA and Clever Leaves. Holdco is expected to become a publicly traded company on NASDAQ, trading under the symbol ‘CLVR’, with an estimated initial commercial value of approximately $ 255 million. The transaction was unanimously approved by the Boards of Directors of SAMA and Clever Leaves and is expected to be completed in the fourth quarter of 2020, subject to regulatory and shareholder approvals, as well as other customary closing conditions. On August 6, 2020, Holdco filed with the United States Securities and Exchange Commission (SEC) a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary statement representing SAMA. in connection with your proposed business combination.

About Cannatrek Ltd
Cannatrek is a publicly owned private company, focused on the Australian and international supply of medical cannabis with operations in Queensland and Victoria, and on the distribution of medical cannabis products across Australia. Cannatrek is about to redefine the medical cannabis industry in Australia, through the convergence of research, cultivation, green technology and distribution, which will put patients first and create a sustainable national company, supported by smart global partnerships. Cannatrek recently received Grand Project status from the Australian federal government as a new greenfield project (on previously undeveloped land) for its 160,000-square-meter project in Shepparton, regional Victoria.

Related:   ERosita telescope on the way to space

Press contacts:
McKenna Miller
KCSA Strategic Communications
+1 347-487-6197

Diana Sigüenza
Strategic Communication Director

Company contact:
Maria claudia heredia
Clever Leaves 360

Disclaimer: Gitenberg brings its readers, one source of useful information for their next new vehicle purchase. We treat every model range independently and understand that not all cars are built for the racetrack and not all cars are built for the school run. Gitenberg applies an unbiased view when compiling reviews for its readers, providing key information and opinions to help make that next new car purchase a lot easier.

If you'd like to buy a car, visit here

Leave a Reply

Your email address will not be published. Required fields are marked *